[2] Balakrishnan, B. Tzafriri, A. R. Seifert, P. Groothuis, A. Rogers, C. and Edelman, E. R., "Strut position, blood flow, and drug deposition-implications for single and overlapping drug-eluting stents", Circulation, 111 (22), 2958 (2005).
[3] LaDisa, J. F., "Stent design properties and deployment ratio influence indexes of wall shear stress: a three-dimensional computational fluid dynamics investigation within a normal artery", J. Appl Physiol., 97 (1), 424 (2004).
[4] Seo, T. Schachter, L. G. and Barakat, A. I., "Computational study of fluid mechanical disturbance induced by endovascular stents", Ann. Biomed Eng., 33 (4), 444 (2005).
[5] Hara, H. Nakamura, M. Palmaz, J. C. and Schwartz, R. S., "Role of stent design and coatings on restenosis and thrombosis", Adv. Drug Deliv. Rev., 58 (3), 377 (2006).
[6] McGinty, S. McKee, S. Wadsworth, R. M. and McCormick, C., "Modelling drug-eluting stents", Math. Med. Biol., 28, 1 (2011).
[7] Pontrelli, G. and De Monte, F., "Mass diffusion through two-layer porous media: an application to the drug-eluting stent", Int. J. Heat and Mass Trans., 50, 3658 (2007).
[8] Pontrelli, G. Mascio, A. D. and De Monte, F., "Local mass non-equilibrium dynamics in multi-layered porous media: application to the drug-eluting stent", Int. J. Heat and Mass Trans., 66 (1), 844 (2013).
[9] Zunino, P., "Multidimensional pharmacokinetic models applied to the design of drug-eluting stents", Cardiovascular Eng., 4 (2), 181 (2004).
[10] Hossainy, S. and Prabhu, S., "A mathematical model for predicting drug release from a biodurable drug-eluting stent coating", J. Biomed. Mater. Res., 87A, 487 (2008).
[11] Siepmann, J. and Siepmann, F., "Modelling of diffusion controlled drug delivery", J. Control. Release, 161, 351 (2012).
[12] McGinty, S. McKee, S. McCormick, C. and Wheel, M., "Release mechanism and parameter estimation in drug-eluting stent systems: analytical solutions of drug release and tissue transport", Math. Med. Biol., 1-24 (2014).
[13] Fredenberg, S. Reslow, M. W. M. and Axelsson, A., "The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems-a review", Int. J. Pharm., 415, 34 (2011).
[14] Prabhu, S. and Hossainy, S., "Modeling of degradation and drug release from a biodegradable stent coating", J. Biomed. Mater. Res., 80A (3), 732 (2007).
[15] Siepmann, J. and Gopferich, A., "Mathematical modeling of bioerodible, polymeric drug delivery systems", Adv. Drug Deliv. Rev., 48 (2-3), 229 (2001).
[16] Joshi, A. and Himmelstein, K. J., "Dynamics of controlled release from bioerodible matrices", J. Membrane Sci., 15, 95 (1991).
[17] Lee, P. I., "Diffusional release of a solute from a polymeric matrix approximate analytical solution", J. Membrane Sci., 7, 255 (1980).
[18] Rossi, F. Casalini, T. Masi, E. R. M. and Perale, G., "Bioresorbable polymer coated drug eluting stent: a model study", Mol. Pharmacol., 9 (7), 1898 (2012).
[19] Rothstein, S. N. Federspiel, W. J. and Little, S. R., "A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices", Biomaterials, 30 (8), 1657 (2009).
[20] Soares, J. S. and Zunino, P., "A mixture model for water uptake, degradation, erosion and drug release from polydisperse polymeric networks", Biomaterials, 31 (11), 3032 (2010).
[21] Siepmann, J. and Gopferich, A., "Mathematical modeling of bioerodible, polymeric drug delivery systems", Adv. Drug Deliv. Rev., 48 (2-3), 229 (2001).
[22] Horner, M. Joshi, S. Dhruva, V. Sett, S. and Stewart, S. F. C., "A two-species drug delivery model is required to predict deposition from drug-eluting stents", Cardiovasc. Eng. Technol., 1 (3), 225 (2010).
[23] Abraham, J. P. Gorman, J. M. Sparrow, E. M. Stark, J. R. and Kohler, R. E., "A mass transfer model of temporal drug deposition in artery walls", Int. J. Heat Mass Trans., 58, 632 (2013).
[24] Pontrelli, G. and De Monte, F., "Modeling of mass dynamics in arterial drug-eluting stents", J. Porous Media, 12 (1), 19 (2009).
[25] Pontrelli, G. and De Monte, F., "A multi-layer porous wall model for coronary drug-eluting stents", Int. J Heat Mass Transfer., 53 (19-20), 3629 (2010).
[26] McGinty, S., "A decade of modelling drug release from arterial stents", Mathematical Biosciences, 257, 80 (2014).
[27] Sakharov, D. V. Kalachev, L. V. and Rijken, D. C., "Numerical simulation of local pharmacokinetics of a drug after intravascular delivery with an eluting stent", J. Drug Target., 10, 507 (2002).
[28] Tzafriri, A. R. Levin, A. D. and Edelman, E. R., "Diffusion-limited binding explains binary dose response for local arterial and tumor drug delivery", Cell Proliferation, 42 (3), 348 (2009).
[29] Tzafriri, A. R. Groothuis, A., Price, G. S. and Edelman, E. R., "Stent elution rate determines drug deposition and receptor-mediated effects", J. Control Release, 161 (3), 918 (2012).
[30] Bozsak, F. Chomaz, J. and Barakat, A. I., "Modeling transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall", Biomech Model Mechanobiol, 13 (2), 327 (2014).
[31] Kuypers, D. R. J., "Benefit-risk assessment of Sirolimus in renal transplantation", Drug Saf., 28 (2), 153 (2005).
[32] Rapamune® prescribing information. Wyeth Pharmaceuticals Inc., December 2005.
[33] A. C. Hindmarsh, suite of nonlinear and differential/algebraic equation solvers, Brown PN SUNDIALS (2005).
[34] Constantinides, A. and Mostoufi, N., "Numerical Methods for Chemical Engineers with Matlab Applications", Prentice Hall: Upper Saddle River, NJ, 1999.
[35] Bae, H. Mrsny, R. J. and Park, K., "Cancer Targeted Drug Delivery: An Elusive Dream", springer, 593 (2013).